The role and regulation of IGFBP-1 phosphorylation in fetal growth restriction

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of cell communication and signaling

• Publication date

  2015-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12079-015-0266-xPMID 25682045PMCID PMC4458246
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Placental alkaline phosphatase de-phosphorylates insulin-like growth factor (IGF)-binding protein-1.

  2014cited by this paper
• Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction.

  2014influential reference
• Phosphorylation of IGFBP-1 at discrete sites elicits variable effects on IGF-I receptor autophosphorylation.

  2013influential reference
• Effects of maternal nutrient restriction, intrauterine growth restriction, and glucocorticoid exposure on phosphoenolpyruvate carboxykinase‐1 expression in fetal baboon hepatocytes in vitro

  2013cited by this paper
• Maternal serum placental growth hormone at 11–13 weeks’ gestation in pregnancies delivering small for gestational age neonates

  2012cited by this paper
• Vulnerability of the fetal primate brain to moderate reduction in maternal global nutrient availability

  2011cited by this paper
• Interactions between subunits of protein kinase CK2 and their protein substrates influences its sensitivity to specific inhibitors

  2011cited by this paper
• Vulnerability of the fetal primate brain to moderate reduction in maternal global nutrient availability

  2011influential reference
• Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress.

  2010cited by this paper
• Site-specific IGFBP-1 hyper-phosphorylation in fetal growth restriction: clinical and functional relevance.

  2010influential reference
• Mammalian Target of Rapamycin (mTOR): Conducting the Cellular Signaling Symphony*

  2010cited by this paper
• Maternal serum concentrations of insulin-like growth factor (IGF)-I and IGF binding protein-1 before and during pregnancy in relation to maternal body weight and composition and infant birth weight

  2010cited by this paper
• Protein Kinase CK2 in Health and Disease

  2009cited by this paper
• Site specific phosphorylation of insulin-like growth factor binding protein-1 (IGFBP-1) for evaluating clinical relevancy in fetal growth restriction.

  2009influential reference
• Hypoxia and leucine deprivation induce human insulin-like growth factor binding protein-1 hyperphosphorylation and increase its biological activity.

  2009influential reference
• Identification of the amniotic fluid insulin‐like growth factor binding protein‐1 phosphorylation sites and propensity to proteolysis of the isoforms

  2009influential reference
• Functional and Complementary Phosphorylation State Attributes of Human Insulin-like Growth Factor-Binding Protein-1 (IGFBP-1) Isoforms Resolved by Free Flow Electrophoresis

  2009influential reference
• Effects of maternal global nutrient restriction on fetal baboon hepatic insulin-like growth factor system genes and gene products.

  2009influential reference
• mTOR signaling at a glance

  2009cited by this paper
• Development of an integrated chromatographic system for on-line digestion and characterization of phosphorylated proteins.

  2008cited by this paper
• Metabolic adjustments to moderate maternal nutrient restriction

  2007influential reference
• Immunoassay of serine-phosphorylated isoform of insulin-like growth factor (IGF) binding protein (IGFBP)-1.

  2007cited by this paper
• Comparison of basal gene expression and induction of CYP3As in HepG2 and human fetal liver cells.

  2007cited by this paper
• The in Vivo Phosphorylation and Glycosylation of Human Insulin-like Growth Factor-binding Protein-5 *S

  2007cited by this paper
• Insulin-like growth factor binding protein (IGFBP-1) involvement in intrauterine growth retardation: study on IGFBP-1 overexpressing transgenic mice.

  2006cited by this paper
• Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins

  2006influential reference
• Elevated circulating insulin-like growth factor binding protein-1 is sufficient to cause fetal growth restriction.

  2006cited by this paper
• Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls.

  2006cited by this paper
• Adult Consequences of Fetal Growth Restriction

  2006cited by this paper
• Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus.

  2006cited by this paper
• “Translating” Tumor Hypoxia: Unfolded Protein Response (UPR)–Dependent and UPR-Independent Pathways

  2006cited by this paper
• Structural basis for the regulation of insulin-like growth factors by IGF binding proteins.

  2006cited by this paper
• Understanding Hypoxia-Induced Gene Expression in Early Development: In Vitro and In Vivo Analysis of Hypoxia-Inducible Factor 1-Regulated Zebra Fish Insulin-Like Growth Factor Binding Protein 1 Gene Expression

  2006cited by this paper
• Maternal plasma concentrations of IGF-1, IGFBP-1, and C-peptide in early pregnancy and subsequent risk of gestational diabetes mellitus.

  2005cited by this paper
• Insulin-like growth factor II and binding proteins 1 and 3 from second trimester human amniotic fluid are associated with infant birth weight.

  2005cited by this paper
• Does antenatal identification of small‐for‐gestational age fetuses significantly improve their outcome?

  2005cited by this paper
• Induction of IGFBP‐1 expression by amino acid deprivation of HepG2 human hepatoma cells involves both a transcriptional activation and an mRNA stabilization due to its 3′UTR

  2005cited by this paper
• Extracellular phosphorylation of C9 by protein kinase CK2 regulates complement‐mediated lysis

  2005cited by this paper
• Posttranslational modifications of decidual IGFBP-1 by steroid hormones in vitro.

  2005cited by this paper
• Effect of maternal diabetes on phosphorylation of insulin‐like growth factor binding protein‐1 in cord serum

  2005influential reference
• Order or chaos? An evaluation of the regulation of protein kinase CK2.

  2004cited by this paper
• Insulin-like growth factor binding protein 1 and human embryonic development during 6 - 10 gestational weeks.

  2004cited by this paper
• Role of N- and C-terminal Residues of Insulin-like Growth Factor (IGF)-binding Protein-3 in Regulating IGF Complex Formation and Receptor Activation*

  2004cited by this paper
• Fetal growth restriction due to placental disease.

  2004cited by this paper
• Evaluation of a bedside test for phosphorylated insulin-like growth factor binding protein-1 in preterm labour.

  2004cited by this paper
• Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties.

  2003cited by this paper
• Generation of Anti-Idiotype Antibodies for Application in Clinical Immunotherapy Laboratory Analyses

  2003cited by this paper
• Phosphorylation of insulin-like growth factor binding protein-3 by deoxyribonucleic acid-dependent protein kinase reduces ligand binding and enhances nuclear accumulation.

  2003cited by this paper
• Maternal-fetal conflict--lessons from a transgene.

  2002cited by this paper
• Insulin Regulation of Insulin-like Growth Factor-binding Protein-1 Gene Expression Is Dependent on the Mammalian Target of Rapamycin, but Independent of Ribosomal S6 Kinase Activity*

  2002cited by this paper
• Cellular actions of the insulin-like growth factor binding proteins.

  2002cited by this paper
• A longitudinal analysis of maternal serum insulin-like growth factor I (IGF-I) and total and nonphosphorylated IGF-binding protein-1 in human pregnancies complicated by intrauterine growth restriction.

  2002influential reference
• Physiological differences in insulin-like growth factor binding protein-1 (IGFBP-1) phosphorylation in IGFBP-1 transgenic mice.

  2001influential reference
• Regulation of IGF bioavailability in pregnancy.

  2001influential reference
• Hypoxia regulates insulin-like growth factor-binding protein 1 in human fetal hepatocytes in primary culture: suggestive molecular mechanisms for in utero fetal growth restriction caused by uteroplacental insufficiency.

  2001cited by this paper
• Mutation of three critical amino acids of the N-terminal domain of IGF-binding protein-3 essential for high affinity IGF binding.

  2001cited by this paper
• Expression, purification and characterization of the structure and disulfide linkages of insulin-like growth factor binding protein-4.

  2001cited by this paper
• Localization of individual subunits of protein kinase CK2 to the endoplasmic reticulum and to the Golgi apparatus

  2001cited by this paper
• Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood.

  2000cited by this paper
• Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities.

  2000cited by this paper
• Substitutions for Hydrophobic Amino Acids in the N-terminal Domains of IGFBP-3 and -5 Markedly Reduce IGF-I Binding and Alter Their Biologic Actions*

  2000cited by this paper
• Phosphorylated insulin-like growth factor binding protein 1 is increased in pregnant diabetic subjects.

  1999influential reference
• Role of insulin-like growth factor binding protein 1 in human pregnancy.

  1999cited by this paper
• Characterization of human insulin-like growth factor-binding proteins by two-dimensional polyacrylamide gel electrophoresis and Western ligand blot analysis.

  1999cited by this paper
• The role of insulin-like growth factor binding protein-1 phosphoisoforms in pregnancies with impaired placental function identified by doppler ultrasound.

  1999cited by this paper
• The N-terminal Disulfide Linkages of Human Insulin-like Growth Factor-binding Protein-6 (hIGFBP-6) and hIGFBP-1 Are Different as Determined by Mass Spectrometry*

  1999cited by this paper
• Phosphorylated insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) inhibits while non-phosphorylated IGFBP-1 stimulates IGF-I-induced amino acid uptake by cultured trophoblast cells.

  1998cited by this paper
• Placental Transport of Leucine and Lysine Is Reduced in Intrauterine Growth Restriction1

  1998cited by this paper
• Phosphoisoforms of insulin‐like growth factor binding protein‐1 in appropriate‐for‐gestational age and small‐for‐gestational age fetuses

  1998cited by this paper
• Phosphorylated insulin‐like growth factor (IGF) —Binding protein‐1 (IGFBP‐1) inhibits while nonphosphorylated IGFBP‐1 stimulates IGF‐I‐induced amino acid uptake by cultured trophoblast cells

  1998cited by this paper
• Phosphoisoforms of insulin-like growth factor binding protein-1 in appropriate-for-gestational-age and small-for-gestational-age fetuses

  1998cited by this paper
• Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia.

  1998cited by this paper
• Intrauterine Growth Retardation: Evidence for the Activation of the Insulin-Like Growth Factor (IGF)-Related Growth-Promoting Machinery and the Presence of a Cation-Independent IGF Binding Protein-3 Proteolytic Activity by Two Months of Life

  1998cited by this paper
• Hypoxia-induced changes in insulin-like growth factors and their binding proteins in pregnant rats.

  1997cited by this paper
• Insulin-like growth factor binding proteins and their role in controlling IGF actions.

  1997cited by this paper
• Fetal and maternal plasma insulin-like growth factors and binding proteins in pregnancies with appropriate or retarded fetal growth.

  1997cited by this paper
• Phosphorylation of insulin-like growth factor binding proteins.

  1997cited by this paper
• Gestational age-dependent expression of insulin-like growth factor-binding protein-1 (IGFBP-1) phosphoisoforms in human extraembryonic cavities, maternal serum, and decidua suggests decidua as the primary source of IGFBP-1 in these fluids during early pregnancy.

  1997cited by this paper
• Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight.

  1996cited by this paper
• A model of intrauterine growth retardation caused by chronic maternal undernutrition in the rat: effects on the somatotrophic axis and postnatal growth.

  1996cited by this paper
• Routine obstetric ultrasound examinations in South Africa: cost and effect on perinatal outcome–a prospective randomised controlled trial

  1996cited by this paper
• Characterization of insulin‐like growth factor binding protein‐1 kinases from human hepatoma cells

  1996cited by this paper
• Insulin-like growth factor-binding protein-1 expression in cultured human bone cells: regulation by insulin and glucocorticoid.

  1996cited by this paper
• The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface.

  1996cited by this paper
• IGF-binding protein mRNAs in the human fetus: tissue and cellular distribution of developmental expression.

  1996cited by this paper
• Rat endometrial stromal cells express the gap junction genes connexins 26 and 43 and form functional gap junctions during in vitro decidualization.

  1996cited by this paper
• Hormonal regulation of circulating insulin-like growth factor-binding protein-1 phosphorylation status.

  1995cited by this paper
• Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth.

  1995cited by this paper
• The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy.

  1994influential reference
• Secretion of insulin-like growth factor binding protein-1 from individual hepatocytes.

  1994cited by this paper
• Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth.

  1994cited by this paper
• Maternal Hypoxia as a Model for Intrauterine Growth Retardation: Effects on Insulin-Like Growth Factors and Their Binding Proteins

  1993cited by this paper
• Phosphorylation of insulin-like growth factor-binding protein-1 increases in human amniotic fluid and decidua from early to late pregnancy.

  1993influential reference
• Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r).

  1993cited by this paper
• Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1. Regulation of its affinity by phosphorylation of serine 101.

  1993influential reference
• Regulation and Function of Insulin-Like Growth Factor-Binding Protein-1

  1993cited by this paper
• Human IGFBP-1 is phosphorylated on 3 serine residues: effects of site-directed mutagenesis of the major phosphoserine.

  1993influential reference
• Role of insulin-like growth factors in embryonic and postnatal growth.

  1993cited by this paper
• Phosphorylation of insulin-like growth factor-binding protein-1 from different sources.

  1993influential reference
• Dexamethasone stimulates expression of insulin-like growth factor binding protein-1 in HEP G2 human hepatoma cells.

  1993cited by this paper

• Pathologic Signaling and Disease Implications of Insulin-like Growth Factor Binding Proteins in Cancer, Cardiovascular Disease, and Fibrosis

  2025cites this paper
• Insulin-Like Growth Factors, Binding Proteins and Their Role in Pregnancy in Patients With Diabetes

  2025cites this paper
• Cord blood levels of insulin‐like growth factor‐1 and insulin‐like growth factor binding protein‐3 correlate with perinatal brain development in fetal congenital heart disease

  2025cites this paper
• Expression of the IGF‑1Ea isoform in human placentas from third trimester normal and idiopathic intrauterine growth restriction singleton pregnancies: Correlations with clinical and histopathological parameters

  2025cites this paper
• AMPK–mTORC1 pathway mediates hepatic IGFBP-1 phosphorylation in glucose deprivation: a potential molecular mechanism of hypoglycemia-induced impaired fetal growth

  2024cites this paper
• Unraveling the unfolded protein response signature: implications for tumor immune microenvironment heterogeneity and clinical prognosis in stomach cancer

  2024cites this paper
• Blood Biomarkers in the Fetally Growth Restricted and Small for Gestational Age Neonate: Associations with Brain Injury

  2023cites this paper
• Developmentally dynamic changes in DNA methylation in the human pancreas

  2023cites this paper
• Effects of melamine and cyanuric acid on placental and fetal development in rats.

  2023cites this paper
• Placental Remote Control of Fetal Metabolism: Trophoblast mTOR Signaling Regulates Liver IGFBP-1 Phosphorylation and IGF-1 Bioavailability

  2023cites this paper
• Maternal, placental, and fetal Insulin-Like Growth Factor-I (IGF-1) and IGF Binding proteins (IGFBPs) in Diabetic pregnancies: Effects on fetal growth and birth size.

  2023cites this paper
• Insulin like growth factor 1 (IGF-1) and IGF binding proteins in obese pregnant women and their babies: Potential effects on placental function and fetal growth

  2023cites this paper
• Cell cycle control by the insulin-like growth factor signal: at the crossroad between cell growth and mitotic regulation

  2022cites this paper
• Sheep recombinant IGF-1 promotes organ-specific growth in fetal sheep

  2022cites this paper
• MMP9 and IGFBP1 Regulate Tumor Immune and Drive Tumor Progression in Clear Cell Renal Cell Carcinoma

  2021cites this paper
• Significance of highly phosphorylated insulin-like growth factor binding protein-1 and cervical length for prediction of preterm delivery in twin pregnancies

  2021cites this paper
• Components of the insulin-like growth factor system in in vivo - and in vitro-derived fetuses of cattle, and the association with growth and development.

  2021cites this paper
• IGFBP-1 in cancer: expression, molecular mechanisms, and potential clinical implications.

  2021cites this paper
• Nutrient Sensing Pathways Mediating IGFBP1 Phosphorylation in FGR

  2020cites this paper
• IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation

  2020cites this paper
• Hyperphosphorylation of fetal liver IGFBP-1 precedes slowing of fetal growth in nutrient restricted baboons and may be a mechanism underlying IUGR.

  2020cites this paper
• Embryonic arsenic exposure reduces intestinal cell proliferation and alters hepatic IGF mRNA expression in killifish (Fundulus heteroclitus)

  2019cites this paper
• Molecular cloning and expression pattern of IGFBP-2a in black porgy (Acanthopagrus schlegelii) and evolutionary analysis of IGFBP-2s in the species of Perciformes

  2019cites this paper
• Prenatal vitamin D and cord blood insulin-like growth factors in Dhaka, Bangladesh

  2019cites this paper
• Co-Localization of Insulin-Like Growth Factor Binding Protein-1, Casein Kinase-2β, and Mechanistic Target of Rapamycin in Human Hepatocellular Carcinoma Cells as Demonstrated by Dual Immunofluorescence and in Situ Proximity Ligation Assay.

  2018cites this paper
• The role of fetal growth restriction in the association between Down syndrome and perinatal mortality

  2018cites this paper
• Regulation of Placental Development and Its Impact on Fetal Growth—New Insights From Mouse Models

  2018cites this paper
• Increased Insulin-like Growth Factor Binding Protein-1 Phosphorylation in Decidualized Stromal Mesenchymal Cells in Human Intrauterine Growth Restriction Placentas

  2018cites this paper
• Novel roles of mechanistic target of rapamycin signaling in regulating fetal growth†.

  2018cites this paper
• Blood-based biomarkers of adverse perinatal outcomes in maternal obesity

  2017cites this paper
• IGF-binding proteins.

  2017cites this paper
• Expression and localization of ARTEMIN in the bovine uterus and embryos.

  2017cites this paper
• Increased IGFBP-1 phosphorylation in response to leucine deprivation is mediated by CK2 and PKC.

  2016cites this paper
• Insulin Like Growth Factor System: How Does it Affect Neonatal Anthropometry? İnsülin Benzeri Büyüme Faktörü Sistemi Neonatal Antropometriyi Nasıl Etkilemektedir?

  2016cites this paper
• Knockout maternal adiponectin increases fetal growth in mice: potential role for trophoblast IGFBP-1

  2016cites this paper
• Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition.

  2016cites this paper
• Insulin-Like Growth Factor Binding Proteins--an Update.

  2015cites this paper